LBIH Biobank
http://www.liv.ac.uk/lbih
The LBIH Biobank has been specifically created to provide SMEs and academic researchers with high quality biosamples, data, and analytical services. We house a vast array of biosamples, both cancerous and non-cancerous, and have the ability to collect bespoke samples and data to suit the needs of researchers. We have access to a wide variety of samples types including, but not limited to, frozen tissue, fresh tissue, blood products, urine and FFPE blocks. The LBIH Biobank can further process these into a number of products such as DNA, frozen sections, and cryo-aliquots. In order to offer a ‘one-stop shop’ for research, we offer additional services such as IHC, next generation sequencing,TMA creation, and project management for studies and projects, to include storage of trial samples.
Services
- Cell culture
- Data analytics
- Digital imaging
- Immunohistochemistry - staining
- Tissue micro array creation
- Nucleic acid extraction
Existing samples:
- Malignant melanoma of eye (disorder)
- Malignant neoplasm of endometrium of corpus uteri (disorder)
- Malignant neoplasm of liver (disorder)
- Malignant tumor of adrenal gland (disorder)
- Malignant tumor of breast (disorder)
- Malignant tumor of cervix (disorder)
- Malignant tumor of colon (disorder)
- Malignant tumor of kidney (disorder)
- Malignant tumor of oral cavity (disorder)
- Malignant tumor of ovary (disorder)
- Malignant tumor of pancreas (disorder)
- Malignant tumor of prostate (disorder)
- Malignant tumor of stomach (disorder)
- Malignant tumor of thyroid gland (disorder)
- Malignant tumor of urinary bladder (disorder)
- Malignant tumor of vulva (disorder)
- Malignant tumour of oesophagus
Contact Information
- Email:
- LBIH-Biobank@liverpool.ac.uk
- Address:
-
3rd Floor William Duncan Building
6 West Derby Street
Liverpool
Lancashire
L7 8TX
England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |